Senior Director, Payer Accounts

Join Immatics and shape the future of cancer immunotherapy; one patient at a time!  

Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting-edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T-cell therapies and TCR bispecifics. 

Why Join Us? 

• Innovative Environment: Help to pioneer advancements in cancer immunotherapy. 

• Collaborative Culture: Be part of a diverse team dedicated to your professional growth. 

• Global Impact: Contribute to therapies that make a lasting impact on patients globally. 

Role Overview:

The Senior Director, Payer Accounts will play a critical leadership role in shaping and executing our U.S. market access strategy with national and regional payers (commercial and government) in preparation for our first cell therapy launch. This is a high-impact, field-based position responsible for building relationships with key payer stakeholders, communicating product value and disease state unmet need, and ultimately securing favorable coverage and reimbursement pathways. This is a highly strategic and autonomous role that is ideal for an experienced national account professional who thrives in fast-paced environment and understands the complexity of launching innovative, high-value therapies.   

 
Reports to: Executive Director, Payer Accounts, Trade and Distribution 
Location: Remote 

Salary Range: $260,000 - $300,000 

Basic Qualifications: 

• Bachelor’s degree with 12+ years of pharmaceutical or biotech market access experience 

• 5+ years of national payer account management experience or similar role calling on payers (i.e., HEOR Field) 

• Cell or gene therapy experience

Preferred Qualifications:  

• MBA or other graduate degree  

• Proven track record of managing national commercial payer accounts, including pre-launch (PIE) and launch readiness for specialty or rare disease products 

• In-depth understanding of health economics, outcomes research, and the evolving reimbursement landscape for high-innovation drugs 

• Cell therapy experience in working with the payer community  

• Strategic thinker with strong analytical skills, capable of navigating complex, ambiguous payer environments with speed and precision

• Experience with innovative reimbursement models for rare diseases and/or cell therapies  

• Strong grasp of payer decision-making processes, formulary management, medical policy development, and specialty pharmacy dynamics 

• Demonstrated ability to thrive in early-stage or launch environments, operating with agility and strategic foresight 

• Excellent communicator who can convey complex scientific and economic data to a multitude of payer stakeholders in driving support for future launch products  

•  “Cultural Champion” who both advocates for themselves and their team—but also who subscribes to rolling up their sleeves and doing what needs to be done across the broader organization to be successful on behalf of patients  

• Strong project management and cross-functional leadership skills 

• Excellent negotiation skills and analytical capabilities 

In this Role You Will:  

• Lead strategic engagement with national and large regional payers in both the commercial and government segments (e.g., UnitedHealthcare, Aetna, Anthem, Cigna, Aetna, Elevance/Anthem, BCBS Plans, State Medicaid Agencies, etc.) 

• Build and manage relationships with key decision-makers across payer organizations, including key pharmacy and medical stakeholders 

• Effectively and efficiently engage with all key targeted accounts while making key prioritization decisions  

• Analyze current treatment guidelines, competitive landscape, and relevant coverage policies to anticipate payer needs and potential barriers, while setting expectations on acceptable future coverage for anzu-cel (TCR-T cell therapy) and other future